163 related articles for article (PubMed ID: 10164064)
1. The application of multiple quality-of-life instruments in individuals with mild-to-moderate psoriasis.
Nichol MB; Margolies JE; Lippa E; Rowe M; Quell J
Pharmacoeconomics; 1996 Dec; 10(6):644-53. PubMed ID: 10164064
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Skindex-29, Dermatology Life Quality Index, Psoriasis Disability Index and Medical Outcome Study Short Form 36 in patients with mild to severe psoriasis.
Fernandez-Peñas P; Jones-Caballero M; Espallardo O; García-Díez A
Br J Dermatol; 2012 Apr; 166(4):884-7. PubMed ID: 22229951
[TBL] [Abstract][Full Text] [Related]
3. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
[TBL] [Abstract][Full Text] [Related]
4. The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: results of a phase II study.
Shikiar R; Willian MK; Okun MM; Thompson CS; Revicki DA
Health Qual Life Outcomes; 2006 Sep; 4():71. PubMed ID: 17005043
[TBL] [Abstract][Full Text] [Related]
5. Impact of psoriasis on quality of life in Iran.
Aghaei S; Moradi A; Ardekani GS
Indian J Dermatol Venereol Leprol; 2009; 75(2):220. PubMed ID: 19293529
[TBL] [Abstract][Full Text] [Related]
6. Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis.
He Z; Lu C; Basra MK; Ou A; Yan Y; Li L
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):109-15. PubMed ID: 22145712
[TBL] [Abstract][Full Text] [Related]
7. The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study).
Youn SW; Lee JH; Yu DY; Kim Y; Kim BS; Seo SJ; Choe YB; Yun SK; Park J; Kim NI; Choi CW; Youn JI; Lee SJ; Lee MG; Kim KJ; Park CJ; Ro YS; Song HJ; Shin BS; Ahn SK; Lee JY; Won YH; Jang MS; Kim KH; Kim MH; Kim TY; Choi JH
J Eur Acad Dermatol Venereol; 2018 Sep; 32(9):1499-1506. PubMed ID: 29430733
[TBL] [Abstract][Full Text] [Related]
8. Demographic characteristics and health-related quality of life of patients with moderate-to-severe psoriasis: The VACAP study.
Daudén E; Pujol RM; Sánchez-Carazo JL; Toribio J; Vanaclocha F; Puig L; Yébenes M; Sabater E; Casado MA; Caloto MT; Aragón B;
Actas Dermosifiliogr; 2013 Nov; 104(9):807-14. PubMed ID: 23827342
[TBL] [Abstract][Full Text] [Related]
9. Reliability and validity of the Chinese version of the Psoriasis Disability Index (PDI) in Chinese patients with psoriasis.
He Z; Lu C; Ou A; Fang J; Wang D; Deng J; Zhang Z; Yu J
Health Qual Life Outcomes; 2012 Apr; 10():37. PubMed ID: 22500772
[TBL] [Abstract][Full Text] [Related]
10. Quality of life and cost of illness in patients with psoriasis in Malaysia: a multicenter study.
Tang MM; Chang CC; Chan LC; Heng A
Int J Dermatol; 2013 Mar; 52(3):314-22. PubMed ID: 23414155
[TBL] [Abstract][Full Text] [Related]
11. Identification of psoriatic patients at risk of high quality of life impairment.
Sojević Timotijević Z; Janković S; Trajković G; Majcan P; Perišić S; Dostanić N; Janićijević Hudomal S; Janković J
J Dermatol; 2013 Oct; 40(10):797-804. PubMed ID: 23961725
[TBL] [Abstract][Full Text] [Related]
12. Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.
Revicki DA; Willian MK; Menter A; Saurat JH; Harnam N; Kaul M
Dermatology; 2008; 216(3):260-70. PubMed ID: 18187944
[TBL] [Abstract][Full Text] [Related]
13. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.
Lundberg L; Johannesson M; Silverdahl M; Hermansson C; Lindberg M
Br J Dermatol; 1999 Dec; 141(6):1067-75. PubMed ID: 10606854
[TBL] [Abstract][Full Text] [Related]
14. Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire.
Dauden E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Caloto MT; Nocea G; Roset M; Lara N
Health Qual Life Outcomes; 2012 May; 10():56. PubMed ID: 22624984
[TBL] [Abstract][Full Text] [Related]
15. Validation of psoriasis disability index (PDI) questionnaire Sinhala version.
Liyanage A; Liyanage G; De Silva V; Akarawita J; Gunasekera C; Imafuku S; Lekamwasam S
Arch Dermatol Res; 2022 Jan; 314(1):61-69. PubMed ID: 33675385
[TBL] [Abstract][Full Text] [Related]
16. [Impact of psoriasis on health-related quality of life].
Ferrándiz Foraster C; García-Díez A; Lizán Tudela L; Bermúdez-Rey L; Badia Llach X
Med Clin (Barc); 2007 Mar; 128(9):325-9. PubMed ID: 17376358
[TBL] [Abstract][Full Text] [Related]
17. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
[TBL] [Abstract][Full Text] [Related]
18. Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial.
Reich K; Nestle FO; Papp K; Ortonne JP; Wu Y; Bala M; Evans R; Guzzo C; Li S; Dooley LT; Griffiths CE
Br J Dermatol; 2006 Jun; 154(6):1161-8. PubMed ID: 16704649
[TBL] [Abstract][Full Text] [Related]
19. Impact of active and stable psoriasis on health-related quality of life: the PSO-LIFE study.
Daudén E; Herrera E; Puig L; Sánchez-Carazo JL; Toribio J; Perulero N
Actas Dermosifiliogr; 2013 Oct; 104(8):685-93. PubMed ID: 23958428
[TBL] [Abstract][Full Text] [Related]
20. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial.
Lebwohl M; Papp K; Han C; Schenkel B; Yeilding N; Wang Y; Krueger GG
Br J Dermatol; 2010 Jan; 162(1):137-46. PubMed ID: 19903183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
